Florida S0886 mandates a study on discounted drug pricing under the 340B Drug Pricing Program for Medicaid recipients.

Florida S0886 requires the Agency for Health Care Administration to conduct a study on the feasibility of implementing discounted drug pricing under the 340B Drug Pricing Program for Medicaid recipients. The study must determine the impact of requiring drug manufacturers, wholesalers, and distributors to sell covered drugs at the 340B discounted price to Medicaid pharmacies. The study results must be submitted to the Governor and the Legislature by January 31, 2027.

Florida S0886 mandates a study on discounted drug pricing under the 340B Drug Pricing Program for Medicaid recipients.

Florida S0886 requires the Agency for Health Care Administration to conduct a study on the feasibility of implementing discounted drug pricing under the 340B Drug Pricing Program for Medicaid recipients. The study must determine the impact of requiring drug manufacturers, wholesalers, and distributors to sell covered drugs at the 340B discounted price to Medicaid pharmacies. The study results must be submitted to the Governor and the Legislature by January 31, 2027.